Semaglutide
A GLP-1 receptor agonist studied and used for type 2 diabetes, chronic weight management, and cardiovascular risk reduction.
Current statusAvailable
Ask on Signal →Quality peptides, available locally in the RGV. Direct contact. Fast response.
A GLP-1 receptor agonist studied and used for type 2 diabetes, chronic weight management, and cardiovascular risk reduction.
A dual GIP and GLP-1 receptor agonist studied and used for type 2 diabetes, chronic weight management, and obesity-related sleep apnea.
An investigational GIP, GLP-1, and glucagon triple-receptor agonist being studied for obesity, type 2 diabetes, and related metabolic conditions.
Send the product name and quantity you are looking for. We’ll reply with current options and pricing.